Chronic B Hepatitis
Mostrando 13-24 de 615 artigos, teses e dissertações.
-
13. Serum regucalcin is a useful indicator of liver injury severity in patients with hepatitis B virus-related liver diseases
Regucalcin is a soluble protein that is principally expressed in hepatocytes. Studies of regucalcin have mainly been conducted in animals due to a lack of commercially available kits. We aimed to develop an enzyme-linked immunosorbent assay (ELISA) to quantify serum regucalcin in patients with hepatitis B virus (HBV)-related disease. High-titer monoclonal an
Braz J Med Biol Res. Publicado em: 30/09/2019
-
14. Hepatitis B and Delta: clinical aspects of patients in the Brazilian Western Amazonia
RESUMO Objetivo: Analisar aspectos clínicos, sorológicos, bioquímicos e hematológicos entre pacientes infectados por vírus das hepatites B (VHB) e Delta (VHD). Método: Estudo transversal, descritivo, retrospectivo, realizado com pacientes cronicamente infectados por VHB e superinfectados por VHD. Resultados: Entre os 112 pacientes selecionados, 74%
Rev. Bras. Enferm.. Publicado em: 16/09/2019
-
15. Molecular epidemiology of Hepatitis delta virus infection in Minas Gerais state from Brazil, an area outside the hyperendemic region of the Amazon Basin
BACKGROUND Hepatitis delta virus (HDV) infections in hepatitis B virus (HBV) carriers are the most severe form of viral hepatitis. HDV prevalence is high in the Brazilian Amazon, but studies in other regions of the country are still scarce and often underestimated its prevalence by including a small numbers of individuals. OBJECTIVE This study aimed to de
Mem. Inst. Oswaldo Cruz. Publicado em: 22/08/2019
-
16. Up-regulation of RIP1 and IPS-1 in chronic HBV infected patients
Abstract IPS-1 and RIP1 are the main downstream molecules of RIG1 and MDA5, as intracytoplasmic receptors, which are the main receptors involved in recognition of internal and external viral double-stranded RNA. In this project, mRNA levels of IPS-1 and RIP1 were investigated in the peripheral blood immune cells of chronic hepatitis B (CHB) patients. IPS-1 a
Genet. Mol. Biol.. Publicado em: 19/08/2019
-
17. HPA-1a/1b could be considered a molecular predictor of poor prognosis in chronic hepatitis C
Abstract INTRODUCTION: HPA polymorphism has been associated with HCV presence and fibrosis progression in chronic hepatitis C. However, it is unknown if there is an association between HPA-1 polymorphism and hepatocellular carcinoma (HCC). Therefore, this study aimed to evaluate HPA-1 polymorphism in the presence of HCC. METHODS: PCR-SSP was used to perfo
Rev. Soc. Bras. Med. Trop.. Publicado em: 27/06/2019
-
18. Association of serum levels of C-reactive protein with CRP-717 T/C polymorphism and viremia in HCV and HBV carriers
Abstract INTRODUCTION: The present study investigated the association of the rs2794521 polymorphism in the CRP gene in individuals with chronic hepatitis B and C, correlating it with markers of hepatic inflammation, fibrosis scores, viral load, and plasma protein levels. METHODS: The study analyzed 185 blood samples obtained from patients with hepatitis B
Rev. Soc. Bras. Med. Trop.. Publicado em: 21/02/2019
-
19. Hepatitis Delta Prevalence in South America: A Systematic Review and Meta-Analysis
Abstract Hepatitis delta virus (HDV) has been associated with acute or chronic hepatitis in Latin America, but there is no prevalence study covering South American countries. This meta-analysis aimed to estimate anti-HDV prevalence through a systematic review of published articles in English, Portuguese and Spanish until December 2017. Searches were conducte
Rev. Soc. Bras. Med. Trop.. Publicado em: 24/01/2019
-
20. Phylogenetic analysis and genotype distribution of Hepatitis B Virus (HBV) in Roraima, Brazil
ABSTRACT Hepatitis B virus (HBV) infection is a serious global health problem. HBV has a high viral genetic diversity, with 10 genotypes recognized. In Brazil, the Roraima State is the third in the Northern region regarding the number of hepatitis B cases. On the other hand, few data on HBV genotyping and phylogenetic analysis are available. The purpose of t
Rev. Inst. Med. trop. S. Paulo. Publicado em: 19/07/2018
-
21. Hepatitis C in Brazil: lessons learned with boceprevir and telaprevir
ABSTRACT In 2012, the first-generation protease inhibitors telaprevir (TVR) and boceprevir (BOC) were introduced in the Brazilian health system for treatment of chronic hepatitis C, after their approval by the National Committee for Health Technology Incorporation (CONITEC). However, these medicines were discontinued in 2015. The short period of use in thera
Rev. Inst. Med. trop. S. Paulo. Publicado em: 28/06/2018
-
22. Atypical crusted scabies in a patient with chronic liver disease caused by hepatitis B and D viruses
Abstract: Crusted scabies is a less common variant of scabies that is highly contagious, difficult to treat and involves infestation by Sarcoptes scabiei var. hominis. The classical clinical presentation includes crusted, scaly and generally non-pruritic lesions usually located on the head, neck, palmar, plantar and periungual region. It was first described
An. Bras. Dermatol.. Publicado em: 2018-03
-
23. Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus
ABSTRACT Despite recent advances in therapy for chronic hepatitis C (CHC), the disease caused by genotype 3 virus (GEN3) is still considered a treatment challenge in certain patient subgroups. The aim of this retrospective study was to evaluate the effectiveness and safety of the peginterferon (Peg-IFN) and ribavirin (RBV) combination treatment for GEN3/CHC
Rev. Inst. Med. trop. S. Paulo. Publicado em: 06/11/2017
-
24. Prognostic factors of the short-term outcomes of patients with hepatitis B virus-associated acute-on-chronic liver failure
OBJECTIVE: To investigate the impact of the baseline status of patients with hepatitis B virus-associated acute-on-chronic liver failure on short-term outcomes. METHODS: A retrospective study was conducted that included a total of 138 patients with hepatitis B virus-associated acute-on-chronic liver failure admitted to the Department of Infectious Diseases
Clinics. Publicado em: 2017-11